Brady Corporation: FY27's 23% EPS growth is one big acquisition, not the core accelerating

Brady beat for its September quarter, and then promised something much bigger. The industrial identification and safety company reported fiscal fourth-quarter adjusted earnings of $1.48 a share against consensus of $1.47, on sales of $436.9 million that topped the roughly $428 million Street estimate, finishing a record year in which adjusted EPS hit $5.29, up 15%. Then it guided fiscal 2027 adjusted EPS to $6.25–$6.75 a share — growth of as much as 28% at the top end.

That headline number is the story, and it deserves more than a glance, because most of it is one acquisition, not the business Brady actually runs.

Where the 23% actually comes from

Brady closes its year in July, so the $5.29 of fiscal 2026 adjusted EPS is already history. The midpoint of its 2027 guide is $6.50, or about $1.21 of growth. Management was unusually transparent about what supplies that increase: roughly $0.80 of it is the newly renamed Intelligent Productivity Solutions (IPS) segment — the ~$1.4 billion all-cash purchase of Honeywell's productivity solutions and services business that closed August 3, 2026 — described as accretion "net of the cost of financing the transaction."

In other words, about two-thirds of next year's earnings growth is a deal Brady signed up for, not organic compounding. The part that is organic is modest: Brady guides its core Identification Solutions (IDS) segment to revenue growing roughly 5% organically next year. That matches 2026, when consolidated organic growth came in at about 5.3% for the full year even as reported sales rose 9.8% to $1.66 billion.

So the market's natural read — "Brady is accelerating toward high-teens earnings growth" — is better stated as: "Brady is stapling a ~40%-of-revenue acquisition onto a ~5% organic grower." Both halves are real. But they are different businesses with different economics, and the 23% growth rate is not evidence that the core is suddenly compounding faster.

The deal changes the math — and the risk

The single most useful number in this report is the margin split. Brady says IDS should run at roughly 20% segment profit as a percentage of sales in 2027, while IPS — which brings about $1.15 billion of the ~$2.9 billion in expected combined revenue, or close to 40% of the company — is expected at low-double-digit segment margins. In plain terms, Brady is becoming a larger, lower-margin company: it is buying fast-topped-line revenue at roughly half its core's profitability.

That has three consequences worth holding onto. First, cash. Brady entered the deal with net cash of $172.2 million after a year in which operating cash flow rose nearly 35% to $244.1 million — a genuinely strong, high-quality quarter that generated the small print most investors miss. Funding a $1.4 billion cash purchase flips that position toward net debt, and management flags that the $0.80 of accretion is after the financing cost.

Second, timing. The guidance says the majority of IPS accretion lands in the second half of fiscal 2027 "as the business is integrated." That is another way of saying the first two quarters carry most of the integration and little of the payoff — the EPS ramp is back-weighted, which is exactly the shape a stock can disappoint on if execution slips.

Third, the quality of that growth. GAAP diluted EPS for the fourth quarter actually fell to $0.96 from $1.04 on acquisition and integration costs, while the adjusted figure rose 17.5%. The gap between the two numbers is the deal's friction, and it will sit on the income statement for years in the form of amortization that the "adjusted" metric strips out.

A narrow beat, a full price, and an H1 test

This is not a quarter that screams "undervalued." The bottom-line beat was a penny, and the revenue surprise was about 2%. Meanwhile the stock has already run: it is up roughly 15% year to date and sits around $90 against a 52-week low of about $71, having retreated from a high near $99. At about $90, the midpoint of the fiscal 2027 adjusted EPS guide ($6.50) puts the stock near 14 times forward adjusted earnings — not expensive if IPS delivers, but the multiple is pricing the deal that was announced back in April, not fresh news from today.

Brady is a good company that did a big, dilutive-to-margins deal. The organic engine is legitimate but slow — roughly 5% growth at a real ~20% segment margin, with an improving cash flow. The upside from here is almost entirely a function of whether IPS, a business that was not part of Brady a month ago, actually integrates on schedule at low-double-digit margins. That is the swing fact, and it will be observable within the next two quarters, when the majority of accretion is supposed to arrive. For a holder, the record year and the guide are reassuring. For a buyer, there is no reason to rush: the price already reflects the deal, and the proof comes second-half weighted. This reads as a wait-and-watch-until-integration-opens rather than a buy-the-dip entry.